The innate immune response to infection, toxins and trauma evolved into networks of interactive, defensive, reparative, regulatory, injurious and pathogenic pathways

Molecular Immunology

Volumn 44, Issue 11, 2007, Pages 2787-2799

  Stavitsky, Abram B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase response; Autonomic nervous system; Complement; Hypothalamic pituitary adrenal axis; Innate immune response; Interferons; MIF; Neuroendocrine; NK cells; TLR

Indexed keywords

COMPLEMENT; INTERFERON; TOLL LIKE RECEPTOR; TOXIN;

ACUTE PHASE RESPONSE; AUTONOMIC NERVOUS SYSTEM; CELL DAMAGE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNITY; INFECTION; INJURY; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

ANIMALS; CYTOKINES; FEMALE; HUMANS; IMMUNITY, NATURAL; INFECTION; INFLAMMATION; MALE; SIGNAL TRANSDUCTION; TOXINS, BIOLOGICAL; WOUND HEALING;

MAMMALIA;

EID: 33947156679     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.01.011     Document Type: Review

References (205)

1. Abe K., Li K., Sacks S.H., and Sheerin N.S. The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin. Exp. Immunol. 136 (2004) 60-66
2. Adachi Y., Bradford B.U., Gao W., Bojes H.K., and Thurman R.G. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20 (1994) 453-460
3. Addis-Lieser E., Kohl J., and Chiaramonte M.G. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J. Immunol. 175 (2005) 1894-1902
4. Akhurst B., Matthews V., Husk K., Smyth M.J., Abraham L.J., and Yeoh G.C. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 41 (2005) 327-335
5. Albrecht E.A., Chinnaiyan A.M., Varambally S., Kumar-Sinha C., Barrette T.R., Sarma J.V., and Ward P.A. C5a-induced gene expression in human umbilical vein endothelial cells. Am. J. Pathol. 164 (2004) 849-859
6. Arcuri F., Cintorino M., Carducci A., Papa S., Riparbelli M.G., Mangioni S., Di Blasio A.M., Tosi P., and Vigano P. Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 131 (2006) 175-182
7. Asgharpour A., Gilchrist C., Baba D., Hamano S., and Houpt E. Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cells. Infect. Immun. 73 (2005) 4522-4529
8. Aslam R., Speck E.R., Kim M., Crow A.R., Bang K.W., Nestel F.P., Ni H., Lazarus A.H., Freeedman J., and Semple J.W. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107 (2006) 637-641
9. Asokan R., Hua J., Young K.A., Gould H.J., Hannan J.P., Kraus D.M., Szakonyi G., Grundy G.J., Chen X.S., Crow M.K., and Holers V.M. Characterization of human receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. J. Immunol. 177 (2006) 383-394
10. Backstrom E., Chambers B.J., Ho E.L., Naidenko O.V., Mariotti R., Fremont D.H., Yokoyama W.M., Kristensson K., and Ljunggren H.G. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur. J. Immunol. 33 (2003) 92-100
11. Bailey M., Engler H., Hunzeker J., and Sheridan J.F. The hypothalamic-pituitary-adrenal axis and viral infection. Viral Immunol. 16 (2003) 141-157
12. Bannikov A.V., Dorofeikov V.V., Freidlin T.S., Shustov E.B., Shcherbak I.G., and Iastrrebov D.Iu. Characteristics of the acute phase reaction in humans with various types of autonomic nervous system regulation during simulated hyperthermia. Ross Fiziol. Zh Im I M Sechenova 86 (2000) 41-45
13. Bas S., Gauthier B.R., Spenato U., Stingelin S., and Gabay C. CD14 is an acute-phase protein. J. Immunol. 172 (2004) 4470-4479
14. Bayne C.J., and Gerwick L. The acute phase response and innate immunity of fish. Dev. Comp. Immunol. 25 (2001) 725-743
15. Bergheim I., Guo L., Davis M.A., Duveau I., and Arteel G.E. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J. Pharmacol. Exp. Ther. 316 (2006) 592-600
16. Bergheim I., McClain C.J., and Arteel G.E. Treatment of alcoholic liver disease. Dig. Dis. 23 (2005) 275-284
17. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., Manogue K.R., Cerami A., and Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365 (1993) 756-759
18. Beutler B., and Poltorak A. Sepsis and evolution of the innate immune response. Crit. Care Med. 29 (2001) 2-6
19. Black S., Wilson A., and Samols D. An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor. J. Immunol. 175 (2005) 1192-1196
20. Blatteis C.M., Sehic E., and Li S. Complement and the pathogenesis of endotoxic fever. Int. J. Biometeorol. 43 (2000) 176-183
21. Bloom B.R., and Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 (1966) 80-82
22. Bohana-Kashtan O., Ziporen L., Donin N., Kraus S., and Fishelson Z. Cell signals transduced by complement. Mol. Immunol. 41 (2004) 583-597
23. Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H.J., and Bora N.S. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 174 (2005) 491-497
24. Bornstein S.R., Zacharowski P., Schumann R.R., Barthel A., Tran N., Papewalis C., Rettori V., McCann S.M., Schulze-Osthoff K., Scherbaum W.A., Tarnow J., and Zacharowski K. Impaired stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16695-16700
25. Breder C.D., Hazuka C., Ghayur T., Klug C., Huginin M., Yasuda K., Teng M., and Saper C.B. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11393-11397
26. Brown D.H., Lafuse W.P., and Zwilling B.S. Host resistance to mycobacteria is compromised by activation of the hypothalamic-pituitary-adrenal axis. Ann. N Y Acad. Sci. 840 (1998) 773-786
27. Bruhn A., Verdant C., Vercruysse V., Su F., Vray B., and Vincent J.L. Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis. Shock 26 (2006) 169-173
28. Bulut Y., Michelsen K.S., Hayrapetian L., Naiki Y., Spallek R., Singh M., and Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem. 280 (2005) 20961-20967
29. Bykov I., Junnikkala S., Pekna M., Lindros K.O., and Meri S. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann. Med. 38 (2006) 280-286
30. Bykov I.L., Vakeva A., Jarvelainen H.A., Meri S., and Lindros K.O. Protective function of complement against alcohol-induced rat liver damage. Int. Immunopharmacol. 4 (2004) 1445-1454
31. Byrne P., McGuirk P., Todryk S., and Mills K.H. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34 (2004) 2579-2588
32. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., Cerami A., and Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377 (1995) 68-71
33. Calandra T., Bernhagen J., Mitchell R.A., and Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179 (1994) 1895-1902
34. Calandra T., and Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit. Rev. Immunol. 17 (1997) 77-88
35. Calandra T., Spiegel L.A., Metz C.N., and Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11383-11388
36. Caragine T.A., Imai M., Frey A.B., and Tomlinson S. Expression of complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity. Blood 100 (2002) 3304-3310
37. Chagnon F., Metz C.N., Bucala R., and Lesur O. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ. Res. 96 (2005) 1095-1102
38. Chang J.Y., Martin D.P., and Johnson Jr. E.M. Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J. Neurochem. 55 (1990) 436-445
39. Chen M.Y., Hu K.Y., Huang C.C., and Song Y.L. More than one type of transglutaminase in invertebrates? A second type of transglutaminase is involved in shrimp coagulation. Dev. Comp. Immunol. 29 (2005) 1003-1016
40. Chesney J., Metz C., Bacher M., Peng T., Meinhardt A., and Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med. 5 (1999) 181-191
41. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., and Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2274-2279
42. Chida Y., Sudo N., Takaki A., and Kubo C. The hepatic sympathetic nerve plays a critical role in preventing Fas induced liver injury in mice. Gut 54 (2005) 994-1002
43. Choudhry M.A., Rana S.N., Kavanaugh M.J., Kovacs E.J., Gamelli R.L., and Sayeed M.M. Impaired intestinal immunity and barrier function: a cause for enhanced bacterial translocation in alcohol intoxication and burn injury. Alcohol 33 (2004) 199-208
44. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. U.S.A. 56 (1966) 72-77
45. Deonarain R., Cerullo D., Fuse K., Liu P.P., and Fish E.N. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110 (2004) 3540-3543
46. DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., and Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol. 162 (1999) 1127-1136
47. Donn R.P., and Ray S.W. Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of key neuroendocrine module. J. Endocrinol. 182 (1994) 1-9
48. Dunn A.J., Ando T., Brown R.F., and Berg R.D. HPA axis activation and neurochemical responses to bacterial translocation from the gastrointestinal tract. Ann. N Y Acad. Sci. 992 (2003) 21-29
49. Edgington T.S., Mackman N., Brand K., and Ruf W. The structural biology of expression and function of tissue factor. Thromb. Haemost. 66 (1991) 67-79
50. Elsner J., Oppermann M., Czech W., Dobos G., Schopf E., Norgauer J., and Kapp A. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur. J. Immunol. 24 (1994) 518-522
51. Esmon C.T. Interactions between the innate immune and blood coagulation systems. Trends Immunol. 25 (2004) 536-542
52. Esquifino A.I., Castrillon P.O., Arce A., Cutrera R.A., and Cardinali D.P. Effect of parasympathetic decentralization on interferon-gamma release from rat submandibular lymph nodes in vitro. Auton. Neurosci. 91 (2001) 10-15
53. Francis K., Lewis B.M., Akatsu H., Monk P.N., Cain S.A., Scanlon M.F., Morgan B.P., Ham J., and Gasque P. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 17 (2003) 2266-2268
54. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. N Y Acad. Sci. 1024 (2004) 124-137
55. Frantz S., Vincent K.A., Feron O., and Kelly R.A. Innate immunity and angiogenesis. Circ. Res. 96 (2005) 15-26
56. Fukuoka Y., Ember J.A., and Hugli T.E. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation. Biochem. Biophys. Res. Commun. 242 (1998) 663-668
57. Furulawa S. Suppression of tissue factor expression by the control of macrophage migration inhibitory factor. Hokkaido Igaku Zassshi 79 (2004) 523-532
58. Garlanda C., Bottazzi B., Bastone A., and Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition and female fertility. Ann. Rev. Immunol. 23 (2005) 337-366
59. Gavrilyuk V., Kalinin S., Hilbush B.S., Middlecamp A., McGuire S., Pelligrino D., Weinberg G., and Feinstein D.L. Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti- inflammatory propertries. J. Neurochem. 92 (2005) 1140-1149
60. Goebel M.U., Czolbe F., Becker H., Janssen O.E., Schedlowski M., and Limmroth V. Effects of interferon-beta 1a on the hypothalamic-pituitary-adrenal axis, leukocyte distribution and mood states in multiple sclerosis patients: results of a 1-year follow-up study. Eur. Neurol. 53 (2005) 182-187
61. Goldmann O., Chhatwal G.S., and Medina E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J. Infect. Dis. 191 (2005) 1280-1286
62. Grencis R.K., and Entwistle G.M. Production of an interferon-gamma homologue by an intestinal nematode: functionally significant or interesting artefact?. Parasitology 115 (1997) 101-106
63. Gunji Y., Lewis J., and Gorelik E. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells. Blood Coagul. Fibrinolysis. 1 (1990) 663-672
64. Guo R.F., Riedemann N.C., Sun L., Gao H., Shi K.X., Reuben J.S., Sarma V.J., Zetoune P.S., and Ward P.A. Divergent signaling pathways in phagocytic cells during sepsis. J. Immunol. 177 (2006) 1306-1313
65. Gustot T., Lemmers A., Moreno C., Nagy N., Quertinmont E., Nicaise C., Franchimont D., Louis H., Deviere J., and Le Moine O. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43 (2006) 989-1000
66. Gutman, H. Schachter,J., Stopel, E., Gutman, R., Lehav, J., 2002. Impaired platelet aggregation in melanoma patients treated with intereferon-alpha-2b adjuvant therapy.
67. Haddad J.J. Alcoholism and neuro-immune-endocrine interactions: physiochemical aspects. Biochem. Biophys. Res. Commun. 323 (2004) 361-371
68. Haddad J.J., Saade N.E., and Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 133 (2002) 1-19
69. Hansen M.K., Nguyen K.T., Goehler L.E., Gayykema R.P., Fleshner M., Maier S.F., and Watkins L.R. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton. Neurosci. 85 (2000) 119-126
70. Hardman M.J., Waite A., Zeef L., Burow M., Nakayama T., and Ashcroft G.S. Macrophage migration inhibitory factor: a central regulator of wound healing. Am. J. Pathol. 167 (2005) 1561-1574
71. Harter L., Mica L., Stocker R., Trentz O., and Keel M. Increased expression of toll-like-receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22 (2004) 403-409
72. Hasenstab D., Lea H., and Clowes A.W. Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 853-859
73. Hawlisch H., and Kohl J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol. Immunol. 43 (2005) 13-21
74. Heeger P.S., Lalli P.N., Lin F., Valujskikh A., Liu J., Mugim N., Ku Y., and Medof M.E. Decay accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201 (2005) 1523-1530
75. Heine H., El-Samalouti V.T., Notzel C., Pfeiffer A., Lentschat A., Kusumoto S., Schmitz G., Hamann L., and Ulmer A.J. CD55/decay accelerating factor is part of the lipopolysaccharide-induced receptor complex. Eur. J. Immunol. 33 (2003) 1399-1408
76. Higgins S.C., Lavelle E.C., McCann C., Keogh B., McNeela E., Byrne P., O'Gorman B., Jarnicki A., McGuirk P., and Mills K.H. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171 (2003) 3119-3127
77. Hillebrandt S., Wasmuth H.E., Weiskirchen R., Hellerbrand C., Keppeler H., Werth A., Schirin-Sokhan R., Wilkens G., Geier A., Lorenzen J., Kohl J., Gressner A.M., Matern S., and Lammert F. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 37 (2005) 835-843
78. Hoek J.B., and Pastorino J.G. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27 (2002) 63-68
79. Hu X., Lim W.P., Meng C., and Ivashkiv L.B. Inhibition of IFN-gamma signaling by glucocorticoids. J. Immunol. 170 (2003) 4833-4839
80. Iba T., Kidokoro A., Fukunaga M., Sugiyama K., Sawada T., and Kato H. Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. Shock 23 (2005) 25-29
81. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., and Thurman R.G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26 (1997) 1530-1537
82. Jana B., Dzienis A., Rogozinska A., Piskula M., Jedlinska-Krakowska M., Wojtkiewicz J., and Majewski M. Dexamethasone- induced changes in sympathetic innervation of porcine ovaries and in their steroidogenic activity. J. Reprod. Dev. 51 (2005) 715-725
83. Jarvelainen H.A., Vakeva A., Lindros K.O., and Meri S. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Clin. Immunol. 105 (2002) 57-63
84. Johnson L.L., Berggren K.N., Szaba F.M., Chen W., and Smiley S.T. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197 (2003) 801-806
85. Kalsner S. Steroid potentiation of responses to sympathomimetic amines in aortic strips. Br. J. Pharmacol. 36 (1969) 582-593
86. Karrow N.A. Activation of the hypothalamic-pituitary-adrenal axis and autonomic nervous system during inflammation and altered programming of the neuroendocrine-immune axis during fetal and neonatal development: lessons learned from the model inflammagen, lipopolysaccharide. Brain Behav. Immun. 20 (2006) 144-158
87. Karst S.M., Wobus C.E., Lay M., Davidson J., and Virgin H.W. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299 (2003) 1575-1578
88. Kim K.I., Malakhova O.A., Hoebe K., Yan M., Beutler B., and Zhang D.E. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling. J. Immunol. 175 (2005) 847-854
89. Koebernick H., Grode L., David J.R., Rohde W., Rolph M.S., Mittrucker H.W., and Kaufmann S.H. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13681-13686
90. Kono H., Rusyn I., Yin M., Gabele E., Yamashina S., Dikalova A., Kadiiska M.B., Connor H.D., Mason R.P., Segal B.H., Bradford B.U., Holland S.M., and Thurman R.G. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. 106 (2000) 867-872
91. Konturek P.C., Brzozowski T., Burnat G., Kwiecien S., Pawlik T., Hahn E.G., and Konturek S.J. Role of brain-gut axis in healing of gastric ulcers. J. Physiol. Pharmacol. 55 (2004) 179-192
92. Krutzik S.R., and Modlin R.L. The role of Toll-like receptors in combating mycobacteria. Semin. Immunol. 16 (2004) 35-41
93. Kudo M., Aosai F., Mun H.S., Norose K., Akira S., Iwakura Y., and Yano A. The role of IFN-gamma and Toll-like receptors in nephropathy induced by Toxoplasma gondii infection. Microbiol. Immunol. 48 (2004) 617-628
94. Kumagi T., Akbar F., Horiike N., and Onji M. Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin. Biochem. 34 (2001) 189-193
95. Laudes I.J., Chu J.C., Sikranth S., Huber-Lang M., Guo R.F., Riedemann N., Sarma J.V., Schmaier A.H., and Ward P.A. Anti- c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am. J. Pathol. 160 (2002) 1867-1875
96. Le-Barillec K., Magalhaes J.G., Corcuff E., Thuizat A., Sansonetti P.J., Phalipon A., and Di Santo J.P. Roles for T and NK cells in the innate immune response to Sgigella flexneri. J. Immunol. 175 (2005) 1735-1740
97. Legler D.F., Loetscher M., Jones S.A., Dahinden C.A., Arock M., and Moser B. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur. J. Immunol. 26 (1996) 753-758
98. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., and Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 8514-8519
99. Leinhase I., Holers V.M., Thurman J.M., Harhausen D., Schmidt O.I., Pietzcker M., Taha M.E., Rittirsch D., Huber-Lang M., Smith W.R., Ward P.A., and Stahel P.F. Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci. 7 (2006) 55
100. Levy O., Coughlin M., Cronstein B.N., Roy R.M., Desai A., and Wessels M.R. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177 (2006) 1956-1966
101. Li S.H., Szmitko P.E., Weisel R.D., Wang C.H., Fedak P.W., Li R.K., Malyguine A.M., Saadi S., Holzknecht R.A., Patte C.P., Sud N., Platt J.L., and Dawson J.R. Induction of procoagulant function in porcine endothelial cells by human natural killer cells. J. Immunol. 159 (1997) 4659-4664
102. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., Medzhitov R.M., and Beg A.A. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166 (2001) 7128-7135
103. Lidington E.A., Haskard D.Q., and Mason J.C. Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood 96 (2000) 2784-2792
104. Marcenaro E., Augugliaro R., Falco M., Castriconi R., Parolini S., Sivori S., Romeo E., Millo R., Moretta L., Bottino C., and Moretta A. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity. Eur. J. Immunol. 33 (2003) 3367-3376
105. Markiewski M.M., Mastellos D., Tudoran R., DeAngelis R.A., Strey C.W., Franchini S., Wetsel R.A., Erdei A., and Lambris J.D. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J. Immunol. 173 (2004) 747-754
106. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu III C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., Hoebe K., Schneewind O., Walker D., Beutler B., Teyton L., Savage P.B., and Bendelac A. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 (2005) 525-529
107. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
108. McCoy R., Haviland D.L., Molmenti E.P., Ziambaras T., Wetsel R.A., and Perlmutter D.H. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182 (1995) 207-217
109. McKim S.E., Gabele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., Connor H.D., Mason R.P., Doll M.A., Hein D.W., and Arteel G.E. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125 (2003) 1834-1844
110. Medzhitov R., and Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
111. Mehlhop E., Whitby K., Oliphant T., Marri A., Engle M., and Diamond M.S. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79 (2005) 7466-7477
112. Metz C.N., and Bucala R. Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv. Immunol. 66 (1997) 197-223
113. Miettinen M., Sareneva T., Julkunen I., and Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2 (2001) 349-355
114. Minagawa M., Deng Q., Liu Z.X., Tsukamoto H., and Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126 (2004) 1387-1399
115. Mitchell R., Bacher M., Bernhagen J., Pushkarskaya T., Seldin M.F., and Bucala R. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J. Immunol. 154 (1995) 3863-3870
116. Mitchison A. Will we survive?. Sci. Am. 269 (1993) 136-144
117. Mizuno Y. Host defense mechanisms against Salmonella infection. Nihon Rinsho Meneki Gakkai Kaishi 27 (2004) 367-372
118. Moffat G.J., and Tack B.F. Regulation of C4b-binding protein gene expression by the actue phase mediators tumor necrosis factor- alpha, interleukin-6 and interleukin-1. Biocehmistry 31 (1992) 12376-12384
119. Mold C., Gewurz H., and Du Clos T.W. Regulation of complement activation by C-reactive protein. Immunopharmacology 42 (1999) 23-30
120. Monsinjon T., Gasque P., Chan P., Ischenko A., Brady J.J., and Fontaine M.C. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J. 17 (2003) 1003-1014
121. Mosher B., Dean R., Harkema J., Remick D., Palma J., and Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J. Surg. Res. 99 (2001) 201-210
122. Muhlen K.A., Schumann J., Wittke F., Stenger S., Van Rooijen N., Van Kaer L., and Tiegs G. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J. Immunol. 172 (2004) 3034-3041
123. Mullarky I.K., Szaba F.M., Berggren K.N., Parent M.A., Kummer L.W., Chen W., Johnson L.L., and Smiley S.T. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect. Immun. 73 (2005) 3888-3895
124. Naldini A., and Carney D.H. Thrombin modulation of natural killer activity in human peripheral lymphocytes. Cell. Immunol. 172 (1996) 35-42
125. Naldini A., Carney D.H., Pucci A., and Carraro E. Human alpha-thrombin stimulates proliferation of interferon-gamma differentiated, growth arrested U937 cells, overcoming differentiation - related changes in expression of p21CIP1/WAF1 and cyclin D1. J. Cell Physiol. 191 (2002) 290-297
126. Nemeth Z.H., Lutz C.S., Csoka B., Deitch E.A., Leibovich S.J., Gause W.C., Tone M., Pacher P., Vizi E.S., and Hasko G. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J. Immunol. 175 (2005) 8260-8270
127. Nesin M., and Cunningham-Rundles S. Cytokines and neonates. Am. J. Perinatol. 17 (2000) 393-404
128. Nishio Y., Minami A., Kato H., Kaneda K., and Nishihira J. Identification of macrophage migration inhibitory factor (MIF) in rat peripheral nerves: its possible involvement in nerve regeneration. Biochim. Biophys. Acta 1453 (1999) 74-82
129. Oak S., Mandrekar P., Catalano D., Kodys K., and Szabo G. TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes. J. Immunol. 176 (2006) 7628-7635
130. Oben J.A., and Diehl A.M. Sympathetic nervous system regulation of liver repair. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 280 (2004) 874-883
131. Oddo M., Calandra T., Bucala R., and Meylan P.R. Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages. Infect. Immun. 73 (2005) 3783-3786
132. Ogawa H., Nishihira J., Sato Y., Kondo M., Takahashi N., Oshima T., and Todo S. An antibody for macrophage migration inhibitory factor suppresses tumor growth and inhibits tumour-associated angiogenesis. Cytokine 12 (2000) 14-30
133. O'Keane V., Dinan T.G., Scott L., and Corcoran C. Changes in hypothalamic-pituitary-adrenal axis measure after vagus nerve stimulation therapy in chronic depression. Biol. Psychiatry 58 (2005) 963-968
134. Oshima S., Onodera S., Amizuka N., Li M., Irie K., Watanabe S., Koyama Y., Nishihira J., Yasuda K., and Minami A. Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett. 580 (2006) 1251-1256
135. Pai R.K., Pennini M.E., Tobian A.A., Canaday D.H., and Harding C.V. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect. Immun. 72 (2004) 6603-6614
136. Pan J.H., Sukhova G.K., Yang J.T., Wang B., Xie T., Fu H., Zhang Y., Satoskar A.R., David J.R., Metz C.N., Bucala R., Fang K., Simon D.I., Chapman H.A., Libby P., and Shi G.P. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109 (2004) 3149-3153
137. Pancer Z., Amemiya C.T., Ehrhardt G.R., Ceitlin J., Gartland G.L., and Cooper M.D. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430 (2004) 174-180
138. Pandit H.B., and Spillert C.B. Effect of methylprednisolone on coagulation. J. Natl. Med. Assoc. 91 (1999) 453-456
139. Pastrana D.V., Raghavan N., FitzGerald P., Eisinger S.W., Metz C., Bucala R., Schleimer R.P., Bickel C., and Scott A.L. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect. Immun. 66 (1998) 5955-5963
140. Perez S.A., Mahaira L.G., Demirtzoglou F.J., Sotiropoulou P.A., Ioannidis P., Iliopoulou E.G., Gritzapis A.D., Sotiriadou N.N., Baxevanis C.N., and Papamichail M. A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival. Blood 106 (2005) 158-166
141. Pritchard, M.T., McMullen, M.R., Wang, Q.F., Cohen, J.I., Stavitsky, A.B., Lin, F., Medof, E.M., Nagy, L.E., 2007. Differential contributions of C3, C5 and decay accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology, in press.
142. Pruett S.B., Zheng Q., Fan R., Matthews K., and Schwab C. Ethanol suppresses cytokine responses induced through Toll-like receptors as well as innate resistance to Escherichia coli in a mouse model for binge drinking. Alcohol 33 (2004) 147-155
143. Rast J.P., Smith L.C., Loza-Coll M., Hibino T., and Litman G.W. Genomic insights into the immune system of the sea urchin. Science 314 (2006) 952-956
144. Reder A., Checinski M., and Chelmieka-Schorr E. The effect of chemical sympathectomy on natural killer cells in mice. Brain. Behav. Immun. 3 (1989) 110-118
145. Renckens R., Roelofs J.J., Florquin S., de Vos A.F., Pater J.M., Lijnen H.R., Carmeliet P., van't Veer C., and van der Poll T. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J. Immunol. 177 (2006) 1189-1196
146. Renn C.N., Sanchez D.J., Ochoa M.T., Legaspi A.J., Oh C.K., Liu P.T., Krutzik S.R., Sieling P.A., Cheng G., and Modlin R.L. TLR activation of langerhans cell-like dendritic cells triggers an antiviral immune response. J. Immunol. 177 (2006) 298-305
147. Repp A.C., Mayhew E.S., Apte S., and Niederkorn J.Y. Human uveal melanoma cells produce macrophage migration inhibitory factor to prevent lysis by NK cells. J. Immunol. 165 (2000) 710-715
148. Rhee S.J., Walker W.A., and Cherayil B.J. Developmentally regulated intestinal expression of IFN-gamma and its target genes and the age-specific response to enteric Salmonella infection. J. Immunol. 175 (2005) 1127-1136
149. Riedemann N.C., Guo R.F., Gao H., Sun L., Hoesel M., Hollman T.J., Wetsel R.A., Zetoune F.S., and Ward P.A. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J. Immunol. 173 (2004) 1355-1359
150. Ritis K., Doumes M., Mastellos D., Micheli A., Giaglis S., Magotti P., Rafail S., Kartalis G., Sideras P., and Lambris J.D. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J. Immunol. 177 (2006) 4794-4802
151. Roger T., David J., Glauser M.P., and Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414 (2001) 920-924
152. Rusnati M., Camozzi M., Moroni E., Bottazzi B., Peri G., Indraccolo S., Amadori A., Mantovani A., and Presta M. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104 (2004) 92-99
153. Sadeghi K., Wessner B., Laggner U., Ploder M., Tamandl G., Friedl J., Zugel U., Steinmeyer A., Pollak A., Roth E., Boltz-Nitulescu G., and Spittler A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness tp pathogen-associated molecular patterns. Eur. J. Immunol. 36 (2005) 361-370
154. Samols D., Agrawal A., and Kushner I. Acute Phase Proteins. Cytokine Reference On-Line (2002), Academic Press, Harcourt, London pp. 1-16
155. Sanda C., Wetsel P., Tsukahara T., Schaley J., Edenberg H.J., Stephens M.A., McClintick J.N., Blatt L.M., Brodsky L., and Taylor M.W. Differential gene induction by type I and type II interferons and their combination. J. Interferon Cytokine Res. 26 (2006) 462-472
156. Santos L.L., and Morand E.F. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien. Med. Wochenschr. 156 (2006) 11-18
157. Satoskar A.R., Bozza M., Rodriguez Sosa M., Lin G., and David J.R. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69 (2001) 906-911
158. Schaefer T.M., Fahey J.V., Wright J.A., and Wira C.R. Migration inhibitory factofretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I:C). Am. J. Reprod. Immunol. 54 (2005) 193-202
159. Schreiber A.D., Parson J., McDermott P., and Cooper R.A. Effect of corticosteroids on the human monocyte IgG and complement receptors. J. Clin. Invest. 56 (1975) 1189-1197
160. Seki E., Tsutsui H., Iimuro Y., Naka T., Son G., Akira S., Kishimoto T., Nakanishi K., and Fujimoto J. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41 (2005) 443-450
161. Sendide K., Reiner N.E., Lee J.S., Bourgoin S., Talal A., and Hmama Z. Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol-3-kinase and cytohesin-1. J. Immunol. 174 (2005) 4210-4219
162. Sheridan J.F., Padgett D.A., Avitsur R., and Marucha P.T. Experimental models of stress and wound healing. World J. Surg. 28 (2004) 327-330
163. Shimizu T., Nishihira J., Watanabe H., Abe R., Honda A., Ishibashi T., and Shimizu H. Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cell. J. Biol. Chem. 279 (2004) 13729-13737
164. Sims P.J., Rollins S.A., and Wiedmer T. Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. J. Biol. Chem. 264 (1989) 19228-19235
165. Siren J., Pirhonen J., Julkunen I., and Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28 and IL-29. J. Immunol. 174 (2005) 1932-1937
166. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., and Moretta A. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors. Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10116-10121
167. Stam T.C., Swaak A.J., Kruit W.H., and Eggermount A.M. Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b. Eur. J. Clin. Invest. 21 Suppl 1 (2002) 79-83
168. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
169. Stassen J.M., Arnout J., and Deckmyn H. The hemostatic system. Curr. Med. Chem. 11 (2004) 2245-2260
170. Stavitsky A.B., and Xianli J. In vitro and in vivo regulation by macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor and cytokine molecules. Cell. Immunol. 217 (2002) 95-104
171. Stavitsky A.B., Metz C., Liu S., Xianli J., and Bucala R. Blockade of macrophage migration inhibitory factor (MIF) in Schistosoma japonicum-infected mice results in an increased adult worm burden and reduced fecundity. Parasite Immunol. 25 (2003) 369-374
172. Steinle J.J., Lindsay N.L., and Lashbrook B.L. Cervical sympathectomy causes photoreceptor specific cell death in the rat retina. Auton. Neurosci. 120 (2005) 46-51
173. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6 (2006) 318-328
174. Straub R.H., Pongratz G., Weidler C., Linde H.J., Kirschning C.J., Gluck T., Scholmerich J., and Falk W. Ablation of the sympathetic nervous system decreases Gram-negative and increases Gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. J. Infect. Dis. 192 (2005) 560-572
175. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., and Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198 (2003) 913-923
176. Tang H., and Brimijoin S. Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody. J. Neuroimmunol. 115 (2001) 53-63
177. Thurman R.G., Bradford B.U., Iimuro Y., Knecht K.T., Arteel G.E., Yin M., Connor H.D., Wall C., Raleigh J.A., Frankenberg M.V., Adachi Y., Forman D.T., Brenner D., Kadiiska M., and Mason R.P. The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J. Gastroenterol. Hepatol. 13 Suppl. (1998) S39-S50
178. Tichomirowa M., Theodoropoulou M., Lohrer P., Schaaf L., Loss M., Uhl E., Lange M., Arzt E., Stalla G.K., and Renner U. Bacterial endotoxin (lipopolysaccharides) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the roll-like receptor 4. J. Neuroendocrinol. 17 (2005) 152-160
179. Tomioka H., Shimizu T., Sato K., Sano C., Kamei T., Emori M., and Saito H. Comparative roles of macrophages and NK cells in the host innate resistance of mice to Mycobacterium fortuitum infection. J. Infect. 48 (2004) 74-80
180. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
181. Trinidad A.G., de la Puerta M.L., Fernandez N., Bayon Y., Crespo M.S., and Alonso A. Coupling of C3bi to IgG inhibits the tyrosine phosphorylation signaling cascade downstream Syk and reduces cytokine induction in monocytes. J. Leukoc. Biol. 79 (2006) 1073-1082
182. Uesugi T., Froh M., Arteel G.E., Bradford B.U., and Thurman R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34 (2001) 101-108
183. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Wheeler M.D., Gabele E., Isayama F., and Thurman R.G. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J. Immunol. 168 (2002) 2963-2969
184. Ulvestad E., Aarseth J.H., Vedeler C., Nyland H., and Myhr K.M. The effects of interferon-alpha 2 on concentration of immunoglobulins, complement and lymphocytes in patients with multiple sclerosis. Scand. J. Immunol. 59 (2004) 10308
185. Uwabe K., Mastsumoto M., and Nagata K. Monokine induced by interferon-gamma acts as a neurotrophic factor on PC12 cells and rat primary sympathetic neurons. J. Bio. Chem. 280 (2005) 34268-34277
186. Vazquez-Torres A., Vallance B.A., Bergman M.A., Finlay B.B., Cookson B.T., Jones-Carson J., and Fang F.C. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J. Immunol. 172 (2004) 6202-6208
187. Vera, P.L., Meyer-Siegler, K.L., 2003. Anatomical location of macrophage migration inhibitory factor in urogenital tissues. BMC Neurosci. 4.17.
188. Vera P.L., Iczkowski K.A., Leng L., Bucala R., and Meyer-Siegler E.L. Macrophage migration inhibitory factor is released as a complex with alpa1-inhibitor-3 in the intraluminal fluid during bladder inflammation in the rat. J. Urol. 174 (2005) 338-343
189. Vilcek J.T. Cytokines in 1995. Cytokine Growth Factor Rev. 7 (1995) 103-106
190. Viriyakosol S., Matthias M.A., Swancutt M.A., Kirkland T.N., and Vinetz J.M. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect. Immun. 74 (2006) 887-895
191. Vitale C., Chiossone L., Cantoni C., Morreale G., Cottalasso F., Moretti S., Pistorio A., Haupt R., Lanino E., Moretta L., and Mingari M.C. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur. J. Immunol. 34 (2004) 3028-3038
192. von Kanel R., and Dimsdale J.E. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur. J. Haematol. 65 (2000) 357-369
193. Walsh M.C., Kim N., Kadono Y., Rho J., Lee S.Y., Lorenzo J., and Choi Y. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24 (2006) 33-63
194. Wang J., Sun R., Wei H., Dong Z., and Tian Z. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury. Int. Immunopharmacol. 6 (2006) 800-807
195. Weatherby K.E., Zwilling B.S., and Lafuse W.P. Resistance of macrophages to Mycobacterium avium is induced by alpha.2-adrenergic stimulation. Infect. Immun. 71 (2003) 22-29
196. Webster J., and Sternberg E.M. Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J. Endocrinol. 181 (2004) 207-221
197. Weiser W.Y., Pozzi L.M., and David J.R. Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. J. Immunol. 147 (1991) 2006-2011
198. Weiser W.Y., Temple P.A., Witek-Giannotti J.S., Remold H.G., Clark S.C., and David J.R. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7522-7526
199. Whitman S.C., Rateri D.L., Szilvassy S.J., Yokoyama W., and Daugherty A. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1049-1054
200. Wick M.J. Living in the danger zone: innate immunity to Salmonella. Curr. Opin. Microbiol. 7 (2004) 51-57
201. Yamamoto N., Kawakami K., Kinjo Y., Miyagi K., Kinjo T., Uezu K., Nakasone C., Naakamatsu M., and Saito A. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma. Microbes Infect. 6 (2004) 1241-1249
202. Yamauchi-Takihara K., Ihara Y., Ogata A., Yoshizaki K., Azuma J., and Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91 (1995) 1520-1524
203. Yeager M.P., Guyre P.M., and Munck A.U. Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol. 48 (2004) 799-813
204. Yin M., Bradford B.U., Wheeler M.D., Uesugi T., Froh M., Goyert S.M., and Thurman R.G. Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol. 166 (2001) 4737-4742
205. Yoshioka T., Morimoto Y., Iwagaki H., Itoh H., Saito S., Kobayashi N., Yagi T., and Tanaka N. Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells. J. Int. Med. Res. 29 (2001) 409-420